Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
Cellbricks Therapeutics logo — Offering a scalable solution to restore lost tissue and orga...

Cellbricks Therapeutics

Offering a scalable solution to restore lost tissue and organ function for millions of patients.

Founded 2016 Germany Berlin, Germany 31 employees Venture round Biotechnology, Life Sciences +2

General Information

Company Name Cellbricks Therapeutics
Founded Year 2016
Location Germany Berlin, Germany
Founders / Decision Makers
Team member
Employees 31
Industries Biotechnology, Life Sciences, Manufacturing +1
Funding Stage Venture round
Business Model B2B, D2C, Platform
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Cellbricks Therapeutics. To contact Cellbricks Therapeutics, visit cellbricks-therapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cellbricks Therapeutics compare?

A PDF of Cellbricks Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cellbricks Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cellbricks Therapeutics

Cellbricks, founded in 2016, is a promising player at the intersection of Biotechnology, Life Sciences, Manufacturing, and 3D Printing. The company is headquartered in Germany, specifically in Berlin, a city renowned for its vibrant startup culture.

The company’s mission is encapsulated in its slogan: "Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice". Leveraging proprietary biofabrication technology, Cellbricks aims to revolutionize the medical field by bioprinting tissue therapeutics that can greatly enhance organ function, offering potential breakthroughs for millions of patients worldwide.

The startup completed its latest Venture Round investment on 31 December 2022, backed by Brooks Hill Partners. The company boasts a diverse, highly skilled team of experts, unified by a commitment to improve healthcare outcomes.

Business keywords: 3D-bioprinting, Bioprinting, Biofabrication, Synthetic Biology, Tissue Engineering, Regenerative Medicine, Tissue Therapeutics, Organ Printing, HealthTech, Recombinant Collagen, Autologous Tissue Implants, Pharmaceuticals, Lab Models, Breast Reconstruction

Services & Products

Development of Cell-based Human Tissue Therapeutics
Biofabrication of Human Tissues
AI-driven Tissue Engineering Solutions
Production of Scalable and Functional Tissues for Medical Use

Target Customers

Healthcare Providers Medical Researchers Biotechnological Companies Patients with Tissue Dysfunction

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Brooks Hill Partners
Brooks Hill Partners
31 Dec 2022
Seed Round Undisclosed 1
b.value AG
b.value AG
05 Sep 2019

Cellbricks Therapeutics Alternatives & Competitors

View All Alternatives
Cellbricks Therapeutics vs
Healshape
Healshape France

Restore your body through the power of self-regeneration

Seed
24 employees
Biotechnology, 3D Printing
Compare Cellbricks Therapeutics vs Healshape
Cellbricks Therapeutics vs
Allevi by 3D Systems
Allevi by 3D Systems United States

Versatile and easy-to-use 3D bioprinters and bioinks. Bring your work to life.

ICO
3 employees
Biotechnology, VR/AR
Compare Cellbricks Therapeutics vs Allevi by 3D Systems
Cellbricks Therapeutics vs
Axolotl Biosystems
Axolotl Biosystems Turkey

Axolotl Biosystems creates and engineers regenerative medicine and tissue engineering products and s...

4 employees
Biotechnology, Health Care
View all alternatives

FAQ About Cellbricks Therapeutics

Offering a scalable solution to restore lost tissue and organ function for millions of patients.
Cellbricks Therapeutics was founded in 2016.
Cellbricks Therapeutics is headquartered in Berlin, Germany.
Cellbricks Therapeutics operates in Biotechnology, Life Sciences, Manufacturing and 3D Printing. Its work centres on 3D-bioprinting, Bioprinting, Biofabrication and Synthetic Biology. Its customers include Healthcare Providers, Medical Researchers and Biotechnological Companies.
Cellbricks Therapeutics has a B2B, D2C and Platform business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Cellbricks Therapeutics has approximately 31 employees.
Cellbricks Therapeutics has completed 2 funding rounds. The latest funding stage is Venture round.
Cellbricks Therapeutics offers: Development of Cell-based Human Tissue Therapeutics, Biofabrication of Human Tissues, AI-driven Tissue Engineering Solutions, Production of Scalable and Functional Tissues for Medical Use.
Top alternatives and competitors to Cellbricks Therapeutics include Healshape, Allevi by 3D Systems, Axolotl Biosystems, Engitix Therapeutics, CHIRON. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellbricks Therapeutics and Healshape are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cellbricks Therapeutics, https://bouncewatch.com/company/cellbricks, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout